FDA 510(k) 101 The Basics

Size: px
Start display at page:

Download "FDA 510(k) 101 The Basics"

Transcription

1 FDA 510(k) 101 The Basics Floyd G. Larson President, PaxMed International San Diego, CA OMTEC June 17, 2010 Chicago Agenda History of 510(k) process FDA s risk based approach FDA guidance and standards Structure of a 510(k) Submission to FDA Follow up with FDA History of 510(k) Program Began May 28, 1976 Medical device amendments to Federal Food Drug & Cosmetic Act ( the Act ) Section 510(k) of the Act Initial regulation of medical devices Grandfathered devices already on market, if risk low (Class I or II) Pre amendments devices New devices cleared if substantially equivalent to devices on market prior to May 28, 1976 Now can be SE to devices that are SE 1

2 2 Section 510(k) of the Act (k) Each person who is required to register under this section and who proposes to begin the introduction or delivery for introduction into interstate commerce for commercial distribution of a device intended for human use shall, at least ninety days before making such introduction or delivery, report to the Secretary or person who is accredited under section 523(a) (in such form and manner as the Secretary shall by regulation prescribe) (1) the class in which hthe device is classified under section 513 or if such person determines that the device is not classified under such section, a statement of that determination and the basis for such person's determination that the device is or is not so classified, and (2) action taken by such person to comply with requirements under section 514 [performance standards] or 515 [premarket approval] which are applicable to the device.... Premarket Notification Original 510(k) process involved sending FDA a letter indicating intent to introduce new device into interstate commerce If no response within 90 days, OK to sell Soon changed to require that a favorable letter from FDA be received prior to marketing Review process now much more rigorous Mini PMA An early 510(k)

3 3 Here it is all 6 pages The beginning of the content This is all there is!

4 How are things different now? 510(k)s may have pages (or more) Solid predicate device(s) are essential Need carefully considered Indications for Use Need strong supporting data Performance testing bench Performance testing animal Performance testing clinical A growing number of submissions Need strong Substantial Equivalence argument Risk based Classification Three Regulatory Classes (level of control based on risk): Class I General Controls (most exempt from 510(k)) Class II General Controls & Special Controls (Guidance Documents, Standards) Class III General Controls & Premarket Approval What is Class III? FDA has determined that Special Controls are not sufficient to ensure safety and effectiveness Class III devices generally are not eligible for 510(k) clearance (need Premarket Approval) Exception for Preamendments Class III devices for which FDA has not yet issued a call for Premarket Approval applications 4

5 Devices Exempt from 510(k) Preamendments devices Unfinished devices Devices exempt by statute or by regulation 739 Class I, 74 Class II Finished devices not sold in U.S. Devices covered under another 510(k) Private labeled devices Custom devices Veterinary devices Is a 510(k) needed? Is it a Medical Device? Is it exempt from 510(k) requirement? Note that it probably is subject to QSR 21CFR 820 Is it a PMA device? Types of 510(k)s Class II and Preamendments Class III Traditional 90 day review Special Rli Relies on Design Controls 30 day review Abbreviated Relies on conformance to standards 5

6 Special 510(k) Used to obtain clearance for a change to a manufacturers own device Same Indication for Use Based on conformance to Design Controls (21CFR ) Submission not easier than Traditional Review time 30 days See FDA guidance at Abbreviated 510(k) Based on conformance to standards and/or FDA guidance documents No advantage for review timing Not commonly used Standards are also used in Traditional 510(k)s Role of Standards Voluntary Organizations such as ASTM, ISO Voting process ASTM by company or individual, ISO by country Recognized by FDA (see FDA recognition list) search.cfm Even when they are not performance standards, they are useful in aiding comparison to historical data or predicate devices 6

7 Substantial Equivalence A device is substantially equivalent if, in comparison to a predicate it: has the same intended use as the predicate; and has the same technological characteristics as the predicate; or has the same intended use as the predicate; and has different technological characteristics and the information submitted to FDA; does not raise new questions of safety and effectiveness; and demonstrates that the device is at least as safe and effective as the legally marketed device. 510(k) Review Flowchart 510(k) Review Flowchart 7

8 8 Reviewer Template for 510(k) Reviewer Template for 510(k) Reviewer Template for 510(k)

9 9 Reviewer Template for 510(k) Reviewer Template for 510(k) Reviewer Template for 510(k)

10 10 What does the 510(k) process accomplish (and what not)? Outcome of 510(k) review determines classification of a device If Substantially Equivalent ( SE ) SE) takes classification of predicate If Not Substantially Equivalent ( NSE ), device is Class III 510(k) clearance is not approval That requires the Premarket Approval (PMA) process A 510(k) is not registration or device listing Nuts andbolts Beginning the Submission Define intended use of device Search for FDA guidance documents FDA database of guidance documents Determine classification FDA database of product codes Look at product codes of similar devices (510(k) summaries) Read classification regulation Search for predicate device candidates Same intended use and product code Similar technological characteristics Multiple predicate devices OK Collect key components

11 Key Components Product list with part numbers for all products to be cleared, including all relevant accessories Engineering drawings for all components on product list Device Description especially characteristicsnot obvious from the drawings (e.g., description of surface treatment and process used) Material Certifications or Material Standards acceptable to FDA Key Components Labeling copies or drafts Instructions for Use (Package Insert) In English Product Labels, with text for most symbols Surgical and/or Prosthetic Manuals Product Brochures List of all claims for which clearance is requested Key Components Packaging description and drawings Planned sterilization method and validation plans including corresponding accepted FDA standard Testing completed (including protocol or standard to which the protocol is written, and final test reports) 11

12 12 Format of a Traditional 510(k) FDA Guidance August 12, sections Some may not apply Maintain numbering and titles Sections of a 510(k) Cover Page Table of Contents 1. Medical Device User Fee Cover Sheet (Form FDA 3601) 2. CDRH Premarket Review Submission Cover Sheet (k) Cover Letter 4. Indications for Use Statement (k) Summary or 510(k) Statement 6. Truthful and Accurate Statement 7. Class III Summary and Certification Sections of a 510(k) 8. Financial Certification or Disclosure Statement 9. Declarations of Conformity and Summary Reports Include Standards Data Reports (Form FDA 3654) for each standard referenced in submission 10 Executive Summary 10. Executive Summary 11. Device Description 12. Substantial Equivalence Discussion 13. Proposed Labeling

13 13 Sections of a 510(k) 14. Sterilization and Shelf Life 15. Biocompatibility 16. Software 17. Electromagnetic Compatibility and Electrical Safety 18. Performance Testing Bench 19. Performance Testing Animal 20. Performance Testing Clinical 21. Other Steps in Writing a 510(k) Write Device Description Summarize bench testing Summarize animal testing (if applicable) Summarize clinical study (if applicable) Write text for other sections Biocompatibility Sterilization and shelf life (include packaging) Write Substantial Equivalence section Steps in Writing a 510(k) Complete administrative sections FDA User Fee Cover Sheet CDRH Cover Sheet 510(k) Cover Letter Indications for Use Statement Indications for Use Statement 510(k) Summary or 510(k) Statement Truthful and Accurate Statement Class III Summary and Certification (if applicable) Financial Certification or Disclosure Statement (if applicable) Declarations of Conformity and Summary Reports Executive Summary Certification re clinical trials databank (if applicable)

14 14 Submitting the 510(k) Submit TWO paper copies or ONE paper copy and ONE electronic (pdf) copy If electronic copy is submitted, see for format Include MS Word file of text for reviewer use Retain an identical file copy Use 8.5 inch x 11 inch paper 3 hole punch left margin Your fancy binder will be discarded (probably used for employee children s school projects) Use 8.5 Complete administrative sections FDA User Fee Cover Sheet CDRH Cover Sheet 510(k) Cover Letter Indications for Use Statement 510(k) Summary or 510(k) Statement Truthful and Accurate Statement Class III Summary and Certification (if applicable) Financial Certification or Disclosure Statement (if applicable) Declarations of Conformity and Summary Reports Executive Summary Certification re clinical trials databank (if applicable) Submitting the 510(k) Submit by traceable courier service to: Food and Drug Administration Center for Devices and Radiological Health Document Mail Center WO66 G New Hampshire Avenue Silver Spring, MD For 510(k)s reviewed by CBER, send to: FDA/CBER 1401 Rockville Pike HFM 99, Room 200N Rockville, MD What s Next? Administrative review for completeness FDA acknowledgement letter Includes assigned K number not a clearance FDA has 90 calendar days to review a Traditional 510(k) Premarket Notification i Target for questions is 75 days FDA has 30 days to review a Special 510(k) Reviewer may call sponsor or consultant with questions If questions can be resolved easily, a hold might be avoided

15 15 What s Next? Questions may come by , FAX or letter (request for additional information AI Letter) Submission will be placed on hold Stops FDA 90 day clock Starts sponsor 30 day clock Et Extensions automatically ti granted tdon request, to a total t of 180 days When sponsor submits response to questions, FDA clock starts running again FDA might ask a second round of formal questions Submission will be placed on hold Stops FDA 90 day clock Starts sponsor 30 day clock Extensions automatically granted on request, to a total of 180 days What s Next? Generally no opportunity for third round of questions If all questions answered satisfactorily Substantially Equivalent letter Clearance to market If reviewer and FDA management not satisfied Not Substantially Equivalent letter Device is Class III Some NSE letters read more like AI letters Invite resubmission as 510(k) with additional information Usually requires clinical or animal data Questions?

16 16 Key FDA website links Classification database 510(k) database Guidance document database GuidanceDocuments/default.htm Device Advice Key FDA Guidance (General) Format for Abbreviated & Traditional 510(k)s GuidanceDocuments/ucm pdf Certifications re clinical trials databank User Fees and Rf Refunds for 510(k)s GuidanceDocuments/ucm pdf Bundling Multiple Devices or Multiple Indications in a Single Submission GuidanceDocuments/ucm pdf To contact us Floyd Larson or Kevin Thomas PaxMed International, LLC Office (858) flarson@paxmed.com kthomas@paxmed.com

510(k) submissions. Getting US FDA clearance for your device: Improving

510(k) submissions. Getting US FDA clearance for your device: Improving Getting US FDA clearance for your device: Improving 510(k) submissions Audrey Swearingen, RAC Director, Regulatory Affairs Telephone: +1 512.222.0263 Email: aswearingen@emergogroup.com Download this white

More information

Use of Standards in Substantial Equivalence Determinations

Use of Standards in Substantial Equivalence Determinations Guidance for Industry and for FDA Staff Use of Standards in Substantial Equivalence Determinations Document issued on: March 12, 2000 U.S. Department Of Health And Human Services Food and Drug Administration

More information

Preparing a US FDA Medical Device 510(K) Submission

Preparing a US FDA Medical Device 510(K) Submission Preparing a US FDA Medical Device 510(K) Submission If you want to introduce your medical device to the US market, you need to obtain clearance from the FDA. This clearance is obtained from the FDA via

More information

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA

Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Class II Special Controls Guidance Document: Intraoral Devices for Snoring and/or Obstructive Sleep Apnea; Guidance for Industry and FDA Document issued on: November 12, 2002 This document supersedes the

More information

Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems UIA Symposium Ronald R.

Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems UIA Symposium Ronald R. Regulatory Submission Strategies and Outlines For Ultrasonic Surgical Devices: Contact and HIFU Systems 2006 UIA Symposium Ronald R. Manna Regulation Governing Medical Devices Europe: Council Directive

More information

510(k) Summary. BioStructures, LLC. Interface Bone Void Filler

510(k) Summary. BioStructures, LLC. Interface Bone Void Filler I UC7 eacv.4df3 5 10(k) Summary DE 3~ 510(k) Summary BioStructures, LLC September 29, 2011 ADMINISTRATIVE INFORMATION Manufacturer Name: Official Contact: Representative/Consultant: BioStructures, LLC

More information

July 10, X-spine Systems, Incorporated David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342

July 10, X-spine Systems, Incorporated David Kirschman, MD Chief Medical Officer 452 Alexandersville Road Miamisburg, Ohio 45342 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service July 10, 2015 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 X-spine

More information

January 7, Dear Ms. Chung:

January 7, Dear Ms. Chung: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 January 7, 2015 Jeisys

More information

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018

BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE. Yuan Xu 18- JAN- 2018 BEST PRACTICE CHANGE CONTROL : DECIDING WHEN TO SUBMIT A 510(K) FOR A DEVICE CHANGE Yuan Xu 18- JAN- 2018 Background AGENDA What is Medical Device? What is 510(k)? Principles of best practices of device

More information

K Michael Kolber Regulatory Affairs

K Michael Kolber Regulatory Affairs 510(k) Number Submitter Name and Address Name: Contact: Address: Consultant, K122105 for the SM I Cardiovascular Patch November 7, 2012 Appendix 4: 510(k) Summary per (21CFRSO7.92) DEC 1 202 K122105 Michael

More information

O(K) SUMMARY. Mega'Gen Co., Ltd , Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: , Fax:

O(K) SUMMARY. Mega'Gen Co., Ltd , Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: , Fax: EZ PLUS IMPLANT SYSTEM 13. 510O(K) SUMMARY Mega'Gen Co., Ltd. 114-8, Eupchun-Ri, Jain-Myun. Gyeongsan, Gyeongbuk South Korea Phone: 82-53-857-5770, Fax: 82-53-857-5432 510(K) Summary 510O(K) SUMMARY AND

More information

Ko0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209

Ko0 -t. Exhibit 2 MAY 3 0? 510 (K) Summay. Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Ko0 -t Exhibit 2 MAY 3 0? 510 (K) Summay Company Name: Columbia Scientific Development, LLC 420 NW I Ith Ave., Suite 617 Portland, Oregon 97209 Contact: Stephen Shulman Phone: 734-663-0132 Fax: 734-663-1306

More information

Donald W. Guthner Orgenix, LLC Ill Hill Road. Douglassville, PA (888) ORGENIX ( ) (484) (FAX) Intramedullary Nails, Nails

Donald W. Guthner Orgenix, LLC Ill Hill Road. Douglassville, PA (888) ORGENIX ( ) (484) (FAX) Intramedullary Nails, Nails K070741 ~, SANATMETAL Manufacturer of Orthopaedic and Traumatologic Products H-3301, Eger Faiskola ut 5. Phone: +(36)36-512-900 Fax: +(36)36-512-932 e-mail: metalasanatmetal.hu 510(k) Statement of Summary

More information

March 8, DxNow, Inc. Kevin Sly Senior Advisor to DxNow, Inc. 401 Professional Drive, Suite 130 Gaithersburg, Maryland

March 8, DxNow, Inc. Kevin Sly Senior Advisor to DxNow, Inc. 401 Professional Drive, Suite 130 Gaithersburg, Maryland March 8, 2018 Kevin Sly Senior Advisor to 401 Professional Drive, Suite 130 Gaithersburg, Maryland 20879-3429 Re: Trade/Device Name: ZyMot ICSI Sperm Separation Device, ZyMot Multi Sperm Separation Device

More information

DEC (k) Summary. X-spine Systems, Inc Corporate Way #212 Centerville, OH Telephone (800) FAX (866)

DEC (k) Summary. X-spine Systems, Inc Corporate Way #212 Centerville, OH Telephone (800) FAX (866) DEC 1 2 2005 Ksjq 5 1 0(k) Premarket Notification Capless' Pedicle Screw System 510(k) Summary ADMINISTRATIVE INFORMATION NManufacturcr Name: X-spine Systems, Inc. 7026 Corporate Way #212 Centerville,

More information

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015

ANDA Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY December 3, 2015 DEPARTMENT OF HEALTH & HUMAN SERVICES Silver Spring, MD 20993 ANDA 060851 Arthur P. Bedrosian, President Armenpharm, Ltd. 49 South Ridge Road P.O. Box D1400 Pomona, NY 10970 Docket No. FDA-2011-P-0081

More information

510(k) 21 Summary of Safety and Effectiveness

510(k) 21 Summary of Safety and Effectiveness 510(k) 21 Summary of Safety and Effectiveness This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirement of 21 CFR 807.92. Submitter's Identification:

More information

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below.

The proposed rule is significant, and the requirements and exceptions are complex. Key provisions of the proposal are described below. ADVISORY Food & Drug FDA ISSUES PROPOSED RULE TO ESTABLISH A UNIQUE DEVICE IDENTIFICATION SYSTEM FOR MEDICAL DEVICES July 16, 2012 On July 11, 2012, the Food and Drug Administration (FDA) published in

More information

U. AUG skeletal dynamics. 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System

U. AUG skeletal dynamics. 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System U. AUG 23 2011 00 skeletal dynamics 510(k) Summary of Safety and Effectiveness Skeletal Dynamics Geminus Volar Distal Radius Plate System Submitter: Skeletal Dynamics, LLC 6905 SW 67 Avenue Suite 201 Miami,

More information

ko~ Tk (K) SUMMARY

ko~ Tk (K) SUMMARY ko~3367-3 13. 510(K) SUMMARY 7-Tk 1 92006 Mega'Gen Co., Ltd. 114-8, Eupchun-Ri, Jain-Myun, Gyeongsan, Gyeongbuk South Korea Phone: 82-53-857-5770, Fax: 82-53-857-5432 510(K) Summary 510O(K) SUMMARY AND

More information

SNuVASivE: 51. 0(k) Premarket Notification Long Lateral Spinal System

SNuVASivE: 51. 0(k) Premarket Notification Long Lateral Spinal System K111410 Page 1 of 2 SNuVASivE: 51 0(k) Premarket Notification Long Lateral Spinal System 510(k) SummaryJU 20201 In accordance with Title 21 of the Code of Federal Regulations, Part 807, and in particular

More information

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 February 15, 2018 AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 Re: K180137 Trade/Device Name: AtriCure cryoice cryo-ablation probe (CRYO3), AtriCure

More information

Bacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015

Bacterin International Incorporated Mr. Howard L. Schrayer 600 Cruiser Lane Belgrade, Montana August 18, 2015 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Bacterin International

More information

Mobile Medical Devices Final Project Assignment Submittal of the MMDA 510(k)

Mobile Medical Devices Final Project Assignment Submittal of the MMDA 510(k) Mobile Medical Devices Final Project Assignment Submittal of the MMDA 510(k) [Base upon http://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/premarketsubmissions/prem arketnotification510k/ucm142651.htm

More information

/tj7-0zq0 510 (k) Summary P

/tj7-0zq0 510 (k) Summary P /tj7-0zq0 510 (k) Summary P Date Prepared: November 28, 2012 Sponsor Information: Pulsecor Limited DEC i 2o12 Level 2, 135 Morrin Road Auckland 1072, New Zealand Sponsor Contact: Andrew Lowe Telephone:

More information

510(K) SUMMARY. Ventus Medical, Inc Shoreway Road, Suite 340 Belmont, CA Menlo Park, CA (650) (phone) (650) (fax)

510(K) SUMMARY. Ventus Medical, Inc Shoreway Road, Suite 340 Belmont, CA Menlo Park, CA (650) (phone) (650) (fax) 510(K) SUMMARY 510(k) Applicant: Contact: Ventus Medical, Inc. 1301 Shoreway Road, Suite 340 Belmont, CA 94002 Menlo Park, CA 94025 (650) 632-4199 (phone) (650) 632-4198 (fax) Cindy Domecus, R.A.C. (US

More information

March 19, Dear Ms. Strohkirch:

March 19, Dear Ms. Strohkirch: DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service March 19, 2015 Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 Treace

More information

Draft Guidance for Industry and FDA Staff

Draft Guidance for Industry and FDA Staff Draft Guidance for Industry and FDA Staff Submission and Review of Sterility Information in Premarket Notification (510(k)) Submissions for Devices Labeled as Sterile DRAFT GUIDANCE This guidance document

More information

NOV Jo 6) ' 510(k) Summary

NOV Jo 6) ' 510(k) Summary NOV 2 9 2004Jo 6) ' 510(k) Summary 1. Applicant Amest Corporation 303194 Espetranza Rancho Santa Margarita, CA 92688 Contact person: John Jest Amnest Corporation 30394 Espcranza Rancho Santa Margarita,

More information

510(k) SUMMARY (Per 21 CFR ) MAY

510(k) SUMMARY (Per 21 CFR ) MAY K130498 page 1 of 3 General Company Information 510(k) SUMMARY (Per 21 CFR 807.92) MAY 3 12013 Name: Contact: Address: Howard Schrayer Regulatory Affairs Consultant 600 Cruiser Lane Belgrade, MT 59714

More information

TELEMED. November 3, Engineering Manager Dariaus ir Gireno str. 42 Vilnius, LT LITHUANIA

TELEMED. November 3, Engineering Manager Dariaus ir Gireno str. 42 Vilnius, LT LITHUANIA DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 10903 New Hampshire Avenue Document Control Center WO66-G609 Silver Spring, MD 20993-0002 TELEMED Engineering Manager

More information

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040

February 15, AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 February 15, 2018 AtriCure, Inc. Melissa Smallwood Regulatory Affairs Specialist 7555 Innovation Way Mason, Ohio 45040 Re: K180138 Trade/Device Name: AtriCure cryoice cryo-ablation probe (CRYO2) Regulation

More information

,,~ 30! Premarket Notification - SomnoMed MAS Flex "S"

,,~ 30! Premarket Notification - SomnoMed MAS Flex S 510(K) SUMMARY This summary of 510(k) safety and effectiveness infornation is being submitted in accordance with the requirements of 21 CFR 807.92. Submitter Information: SomnoMed Inc Date Summary Prepared:

More information

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM'

NEURONETICS. 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' NEURONETICS 510(k) SUMMARY NEUROSTAR TMS THERAPY SYSTEM' 510(k) Owner: Neuronetics, Inc. DEC 1 6 Z008 1 Great Valley Parkway, Suite 2 Malvern, PA 19355 Phone: 610-640-4202 Fax: 610-640-4206 Company Contact:

More information

510(k) Summary. Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124

510(k) Summary. Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124 K(102998 Page I of 2 510(k) Summary Device Trade Name: Congruent Bone Plate System J A.N 4 21 Manufacturer: Contact: Prepared by: Acumed, LLC 5885 NW Cornelius Pass Road Hillsboro, OR 97124 Mr. Ed Boehmer

More information

Dear Cecilia Ceng: U.S. Food & Drug Administration New Hampshire Avenue Doc ID# Silver Spring, MD

Dear Cecilia Ceng: U.S. Food & Drug Administration New Hampshire Avenue Doc ID# Silver Spring, MD November 8, 2017 Cassie Lee Vice President Guangzhou GLOMED Biological Technology Co., Ltd. Suite 306, Kecheng Mansion, No.121 Science Road, Guangzhou Science Park Guangzhou, 510663 CN Re: K170229 Trade/Device

More information

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.

Guidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance

More information

5101K] SUMMARY [as required by (c)]

5101K] SUMMARY [as required by (c)] 735-10, Ancheong-dong, Gwangsan-gu, Gwangju, Korea FAX:+82-62-954-1055 http://www. inarex. co. kr IN AR E)( TEL:+82-62-952-1052 INAREX CORPORATION 5101K] SUMMARY [as required by 807.92(c)] AUG 2 7 2008

More information

510(k) SUMMARY. Bristol, PA President. PhysioFlow Q-Link. Classification Name: Impedance plethysmograph (21 CER 870.

510(k) SUMMARY. Bristol, PA President. PhysioFlow Q-Link. Classification Name: Impedance plethysmograph (21 CER 870. KC140102 Page 1 of 3 510(k) SUMMARY FB121 This 5 10(k) summary is submitted in accordance with the requirements of SMDA 1990 and 21 CER 807.87 Establishment Relistration Number: 3005467960 Address of Manufacturer:

More information

Contact [UlS agent: Dong Guk Ha. April Lee MegaGenImplant Co., Ltd.

Contact [UlS agent: Dong Guk Ha. April Lee MegaGenImplant Co., Ltd. 5 10kW Submission Xeed PAnyffide Internal Imlant System MAR 2 7 2013 510(k) Summary This summary of 510(k) safety and effectiveness information is being submitted in accordance with requirements of 21

More information

510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805

510(k) SUMMARY STATEMEMT. Mettler Traction Device, MTD 4000 OCT Mettler Electronics Corp South Claudina Street Anaheim, CA 92805 510(k) SUMMARY STATEMEMT OCT - 8 2009 Mettler Traction Device, MTD 4000 Submitter's Name: Address: Mettler Electronics Corp. 1333 South Claudina Street Anaheim, CA 92805 Telephone: 714-533-2221 x324 Fax:

More information

SECTION 2. SUMMARY AND CERTIFICATION

SECTION 2. SUMMARY AND CERTIFICATION SECTION 2. SUMMARY AND CERTIFICATION A. 510(K) SUMMARY JUL 29 Summary of Safety and Effectiveness In accordance with 21 CFR 807.92, the following information constitutes the Oticon Medical summary for

More information

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA.

Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA. Responsibilities of Laser Light Show Projector Manufacturers, Dealers, and Distributors; Final Guidance for Industry and FDA (Laser Notice 51) Document issued on: May 27, 2001 U.S. Department of Health

More information

SECTION 2. SUMMARY AND CERTIFICATIOIov

SECTION 2. SUMMARY AND CERTIFICATIOIov SECTION 2. SUMMARY AND CERTIFICATIOIov 1 4 2 00 8 A. 510(K) SUMMARY.Summary of Safetv and Effctiveness In accordance with 21 CFR 807.92, the following information constitutes the Oticon Medical summary

More information

TOBACCO PRODUCT OR MEDICAL PRODUCT?

TOBACCO PRODUCT OR MEDICAL PRODUCT? TOBACCO PRODUCT OR MEDICAL PRODUCT? Priscilla Callahan-Lyon, MD Deputy Director Division of Individual Health Science Office of Science, CTP Grail Sipes, JD Director Office of Regulatory Policy, CDER Disclaimer:

More information

MAY Page 1 of 2

MAY Page 1 of 2 MAY 2 22012 Page 1 of 2 2. 5 10(k) SUMMARY Sponsor Name: 510(k) Contact: Consensus Orthopedics, Inc. 1115 Windfield Way, Suite 100 El Dorado Hills, CA 95762 Matthew M. Hull, RAC Phone: (916) 355-7156/

More information

September 28, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852

September 28, Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 September 28, 2011 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Re: Docket No. : Center for Devices and Radiological Health 510(k)

More information

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044

Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs 425 Privet Road Horsham, PA 19044 DEPARTMENT OF HEALTH & HUMAN SERVICES ANDA 090783 Food and Drug Administration Silver Spring, MD 20993 Teva Pharmaceuticals USA Attention: Scott D. Tomsky Vice President, US Generics Regulatory Affairs

More information

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated

SUMMARY: The Food and Drug Administration (FDA) is requesting public input on updated This document is scheduled to be published in the Federal Register on 11/22/2017 and available online at https://federalregister.gov/d/2017-25245, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the

Three-Month Extension of Certain Tobacco Product Compliance Deadlines Related to the This document is scheduled to be published in the Federal Register on 05/15/2017 and available online at https://federalregister.gov/d/2017-09754, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Section III 510(k) Summary

Section III 510(k) Summary 510(k) Submission Report for Contec Pocket Fetal Doppler CD Y L- Internal Report SN: A2008-005-031 Section III 510(k) Summary As Required by CFR 807.92 FEB 2 5 2009 Sponsor: Contec Medical Systems Co.,

More information

TISSUELINKO., Simply Better Surgery TM

TISSUELINKO., Simply Better Surgery TM Special 510(k): Part A TissueLink Medical, Inc. - Aquamantys Pump Generator System TISSUELINKO., Simply Better Surgery TM OCT 2 5 00 510(k) Summary of Safety and Effectiveness This summary of 510(k)-safety

More information

SPINE. 510(k) Summary. Anterior/anterolateral noncervical use (KWQ) (Prodct Cde):Noncervical

SPINE. 510(k) Summary. Anterior/anterolateral noncervical use (KWQ) (Prodct Cde):Noncervical k10 3?I13 SPINE 510(k) Summary FB-22f FB 24f This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92. Preparation Date: November

More information

Introduction. Current status of 510(k) clinical data requirements. 1 Current Status&Considerations:

Introduction. Current status of 510(k) clinical data requirements. 1   Current Status&Considerations: 510(k) Current Status&Considerations: Conducting a Well-Controlled Clinical Study When Clinical Data is Required Introduction In an effort to promote innovation while protecting the population at large,

More information

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer

Medidée Services SA. Nano-Tera.ch. 05 February 2015 part 4. Intro ISO GMP - GLP Pierre-Alain Sommer Nano-Tera.ch 05 February 2015 part 4 Intro ISO GMP - GLP Pierre-Alain Sommer Pierre-alain.sommer@medidee.com www.medidee.com Nano-Tera 2015 05.02.2015 Introduction to ISO 13485, cgmp s and GLP s Context

More information

Instrument, Surgical, Powered, Laser 79-GEX 21I CFR878-48

Instrument, Surgical, Powered, Laser 79-GEX 21I CFR878-48 kor~f ¼ UL 2 62004 This 510(K) Summary of safety and effectiveness for the Millennium Dental Technologies PerioLase Dental Laser System is submitted in accordance with the requirements of the SMDA 1990

More information

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17

TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 TSDR Pharmacy Inc. dba brandmd Skin Care 11/9/17 Division of Pharmaceutical Quality Operations IV 19701 Fairchild, Irvine, CA 92612-2506 Telephone: 949-608-2900 Fax: 949-608-4417 WARNING LETTER VIA SIGNATURE

More information

Draft Guidance for Industry and FDA Staff. Class II Special Controls Guidance Document: External Penile Rigidity Devices

Draft Guidance for Industry and FDA Staff. Class II Special Controls Guidance Document: External Penile Rigidity Devices Draft Guidance for Industry and FDA Staff Class II Special Controls Guidance Document: External Penile Rigidity Devices DRAFT GUIDANCE This guidance document is being distributed for comment purposes only.

More information

Overview of the Legal Framework for Medical Device Regulation in the United States

Overview of the Legal Framework for Medical Device Regulation in the United States 1 Overview of the Legal Framework for Medical Device Regulation in the United States Ellen J. Flannery This chapter provides an overview of the legal framework for medical device regulation in the United

More information

Classification Name, Classification Number, Class, Classification Reference: 74BWS I DSK I DXN I

Classification Name, Classification Number, Class, Classification Reference: 74BWS I DSK I DXN I 510(k) Summary Date of Summary Preparation: February 25,2001 Manufactures Contact Person: Trade Name: Mark Rison Sr. Dir. QARA (2 10) 696-8800 FAX (2 10) 696-8800 Colin Medical Instruments Corp. 5850 Farinon

More information

Guidance for Industry

Guidance for Industry Reprinted from FDA s website by Guidance for Industry Bar Code Label Requirements Questions and Answers (Question 12 Update) DRAFT GUIDANCE This guidance document is for comment purposes only. Submit comments

More information

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry

ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry ANDA Submissions Refuse to Receive for Lack of Proper Justification of Impurity Limits Guidance for Industry DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments

More information

Primer: Medical Device User Fee Amendments Han Zhong l September 2011

Primer: Medical Device User Fee Amendments Han Zhong l September 2011 Primer: Medical Device User Fee Amendments Han Zhong l September 2011 Introduction The Medical Device User Fee and Modernization Act (MDUFMA or MDUFA) is a set of agreements between the Food and Drug Administration

More information

April 30, By Electronic Mail

April 30, By Electronic Mail April 30, 2018 By Electronic Mail Dr. Scott Gottlieb, Commissioner Office of the Commissioner Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 CommissionerFDA@fda.hhs.gov

More information

International Pharmaceutical Aerosol Consortium on Regulation and Science

International Pharmaceutical Aerosol Consortium on Regulation and Science International Pharmaceutical Aerosol Consortium on Regulation and Science 1500 K Street NW Washington DC 20005 Telephone +1 202 230 5607 Fax +1 202 842 8465 Email info@ipacrs.org Web www.ipacrs.org Submitted

More information

General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff

General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff General Wellness: Policy for Low Risk Devices Guidance for Industry and Food and Drug Administration Staff Document issued on: July 29, 2016. The draft of this document was issued on January 20, 2015.

More information

Standards of Conduct for Transmission Providers

Standards of Conduct for Transmission Providers Standards of Conduct for Transmission Providers Posted and Effective as of December 30, 2016 Puget Sound Energy ( PSE ) is a public utility that owns, operates, and controls facilities used for the transmission

More information

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization

Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization Draft Guidance for Industry and Food and Drug

More information

FDA s 510(k) Working Group

FDA s 510(k) Working Group Understing the Premarket Notification (510(k)) Process FDA s 510(k) Working Group Presentation to the Institute of Medicine March 1, 2010 Donna-Bea Tillman, Ph.D. Director, Office of Deice Ealuation U.S.

More information

Talon Compounding Pharmacy 10/3/17

Talon Compounding Pharmacy 10/3/17 Talon Compounding Pharmacy 10/3/17 Office of Pharmaceutical Quality Operations, Division II 4040 N. Central Expressway, Suite 300 Dallas, Texas 75204 October 3, 2017 CMS Case # 522630 VIA UPS EXPRESS WARNING

More information

Strengthening the Center for Devices and Radiological Health s 510(k) Review Process February 18, 2010

Strengthening the Center for Devices and Radiological Health s 510(k) Review Process February 18, 2010 Strengthening the Center for Devices and Radiological Health s 510(k) Review Process February 18, 2010 R. Glenn Neuman, Director of Scientific Affairs NWRSInc.@gmail.com NewWorldReg.com NWRS was founded

More information

ATTACHMENT A AdvaMed Comments Draft-Guidance for Industry and FDA Staff -510(k) Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device Line(s) No. Line or lines numbers of the

More information

NDA NDA APPROVAL

NDA NDA APPROVAL DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Silver Spring MD 20993 NDA 022200 NDA APPROVAL Amylin Pharmaceuticals, Inc. Orville Kolterman, M.D. Sr. Vice President, Research & Development

More information

Planning For The FDA s 'Deeming Rule' For E- Cigarettes

Planning For The FDA s 'Deeming Rule' For E- Cigarettes Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,

More information

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory

Clinical Chemistry and Clinical Toxicology Devices Panel of the Medical Devices Advisory This document is scheduled to be published in the Federal Register on 03/01/2018 and available online at https://federalregister.gov/d/2018-04167, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update

FDLI s Enforcement, Litigation, and Compliance Conference. Center for Tobacco Products Office of Compliance and Enforcement 2017 Update FDLI s Enforcement, Litigation, and Compliance Conference Center for Tobacco Products Office of Compliance and Enforcement 2017 Update Ann Simoneau, Director Office of Compliance and Enforcement Center

More information

Our medtech experts are yours. 510(k)s for Connected Medical Devices.

Our medtech experts are yours. 510(k)s for Connected Medical Devices. Our medtech experts are yours. 510(k)s for Connected Medical Devices. David Amor, MSBE, CQA Principal, Medgineering david@medgineering.com www.medgineering.com Agenda. What is a 510(k)? How do we determine

More information

In Vitro Diagnostic Testing for Direct Oral Anticoagulants- Premarket Review

In Vitro Diagnostic Testing for Direct Oral Anticoagulants- Premarket Review In Vitro Diagnostic Testing for Direct Oral Anticoagulants- Premarket Review Cardiac Safety Research Consortium December 3, 2015 Lea Carrington Division of Immunology and Hematology Devices Office of In

More information

Introduction to Product Regulation Under the Family Smoking Prevention & Tobacco Control Act

Introduction to Product Regulation Under the Family Smoking Prevention & Tobacco Control Act Introduction to Product Regulation Under the Family Smoking Prevention & Tobacco Control Act Presentation for the Tobacco Merchants Association by John Manthei May 23, 2011 Latham & Watkins operates worldwide

More information

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements

RE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov

More information

FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC

FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs Hyman, Phelps & McNamara, P.C. Washington, DC AIPLA Annual Meeting Joint Biotechnology Committee/ Special Committee on FDA Law Program October 21, 2010 Marriott Wardman Park Hotel Washington, DC FDA Regulation of Diagnostic Tests Jeffrey N. Gibbs

More information

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing;

Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public Hearing; 4160-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 15 [Docket No. FDA-2013-N-0402] Generic Drug User Fee Amendments of 2012; Regulatory Science Initiatives; Public

More information

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j))

The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) The Tobacco Control Act s Premarket Review Authorities: Reports on Substantial Equivalence and Exemption Requests (905(j)) January 12, 2011 Cristi Stark, MS Senior Regulatory Health Project Manager Office

More information

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products

UNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products UNITED STATES REGULATION OF TOBACCO PRODUCTS Presented by Mitch Zeller Center Director FDA Center for Tobacco Products May 24, 2016 OVERVIEW OF TODAY S PRESENTATION Highlights of the Deeming Final Rule

More information

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for

Opioid Policy Steering Committee: Prescribing Intervention--Exploring a Strategy for This document is scheduled to be published in the Federal Register on 12/13/2017 and available online at https://federalregister.gov/d/2017-26785, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

INRANGE SYSTEMS. Citizen Petition

INRANGE SYSTEMS. Citizen Petition INRANGE SYSTEMS I~ I~ ;111Q I~ I tim@ II lifi11 Ill~ 1!1 II: I@ ;I@~ lij December 26, 2014 ZOI5 JA. -5 P 1: 15 Division of Dockets Management Food and Drug Administration 5630 Fishers Lane, Room 1061 (HFA-305)

More information

Guidance - IDE Early/Expanded Access for Devices

Guidance - IDE Early/Expanded Access for Devices Guidance - IDE Early/Expanded Access for Devices An unapproved medical device may normally only be used on human subjects through an approved clinical study in which the subjects meet certain criteria

More information

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process

Comments of the Patient, Consumer, and Public Health Coalition. Strengthening the Center for Devices and Radiological Health s 510(k) Review Process March 19, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville, MD 20852 Comments of the Patient, Consumer, and Public Health Coalition on Strengthening

More information

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for

Withdrawal of Proposed Rule on Supplemental Applications Proposing Labeling Changes for This document is scheduled to be published in the Federal Register on 12/14/2018 and available online at https://federalregister.gov/d/2018-27098, and on govinfo.gov 4164-01-P DEPARTMENT OF HEALTH AND

More information

MAR (k) SUMMARY. Stanmore Implants Worldwide Ltd JTS Extendible Implant Preparation Date: March 17, A ppl ica nt/spo0nsor:

MAR (k) SUMMARY. Stanmore Implants Worldwide Ltd JTS Extendible Implant Preparation Date: March 17, A ppl ica nt/spo0nsor: 510(k) SUMMARY MAR 2 2 201 Stanmore Implants Worldwide Ltd JTS Extendible Implant Preparation Date: March 17, 2011 A ppl ica nt/spo0nsor: Contact Person: Proprietary name: Common or Usual Name: Classification

More information

Agency Information Collection Activities; Submission for Office of Management and Budget

Agency Information Collection Activities; Submission for Office of Management and Budget This document is scheduled to be published in the Federal Register on 01/28/2016 and available online at http://federalregister.gov/a/2016-01690, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN

More information

Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products

Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Products Effective and Compliance Dates Applicable to Retailers, Manufacturers, Importers, and Distributors of Newly Deemed Tobacco Quick Facts Retailers that mix and prepare e-liquids or create or modify vaporizers

More information

Using and Referencing ISO and IEC Standards for Technical Regulation

Using and Referencing ISO and IEC Standards for Technical Regulation Using and Referencing ISO and IEC Standards for Technical Regulation Third ANSI Conference on U.S. Leadership in ISO and IEC May 23-24, 24, 2007 Chicago, IL David P. Kelly, M.I.M. Office of International

More information

Key CDRH Regulatory Initiatives

Key CDRH Regulatory Initiatives Key CDRH Regulatory Initiatives Revamping the Submission Process Creating New Strategies Ralph F. Hall University of Minnesota Law School Counsel Faegre Baker & Daniels May 8, 2012 Purpose of Today s Program

More information

Safety Evaluation for Substances Directly Added to Food

Safety Evaluation for Substances Directly Added to Food Safety Evaluation for Substances Directly Added to Food Teresa Croce, PhD Office of Food Additive Safety Center for Food Safety and Applied Nutrition US Food and Drug Administration How Does FDA Regulate

More information

WCPT Subgroups. Information Pack: September 2011

WCPT Subgroups. Information Pack: September 2011 WCPT Subgroups Information Pack: 1. Background... 2 2. Requirements for WCPT subgroups... 3 3. Duties of WCPT subgroups... 3 4. Rights of WCPT Subgroups... 4 5. WCPT website... 4 6. Applications... 4 7.

More information

Inspections, Compliance, Enforcement, and Criminal Investigations

Inspections, Compliance, Enforcement, and Criminal Investigations Home Inspections, Compliance, Enforcement, and Criminal Investigations Enforcement Actions Warning Letters Inspections, Compliance, Enforcement, and Criminal Investigations Burzynski Research Institute

More information

U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. Preface

U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health. Preface U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Preface Public Comment: The Food and Drug Administration (FDA) is announcing the availability

More information

Medicare Part D Overutilization Monitoring System

Medicare Part D Overutilization Monitoring System Medicare Part D Overutilization Monitoring System Lisa Thorpe, Division of Part D Policy Gary Wirth, Division of Clinical and Operational Performance Medicare Drug Benefit and C&D Data Group July 17, 2013

More information